This analysis revealed M6 subtype of acute myeloid leukemia as a cancer type in which CIP2A and representative genes of each level of the pathway (EGFR, MEK2 and ETS1) were significantly upregulated in two different genome wide leukemia studies [31], [32] (Fig. 8). The gene discussed is MAP2K2; the disease is acute myeloid leukemia.